Cargando…
Roadblocks for integration of novel biomarker concepts into clinical routine: the peptoid approach
In the field of Alzheimer’s disease, the development of novel biomarker assays is critically needed to improve the early diagnosis of the disease, to estimate the risk of developing the disease, to predict the rate of cognitive decline, and to monitor the response or effectiveness of a therapy. The...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055076/ https://www.ncbi.nlm.nih.gov/pubmed/25031636 http://dx.doi.org/10.1186/alzrt253 |